Last reviewed · How we verify
Mefanamic Acid
At a glance
| Generic name | Mefanamic Acid |
|---|---|
| Sponsor | Haisco Pharmaceutical Group Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Vitamin E Plus Mefenamic Acid Versus Mefenamic Acid Alone for Treating Primary Dysmenorrhea in Women (PHASE4)
- Management of Abnormal Uterine Bleeding (NA)
- A Trial Investigating Lu AF28996 in Healthy Adult Participants (PHASE1)
- Evaluation of the Effects of Mefenamic Acid and Dexketoprofen on Postoperative Wisdom Dental Surgery (NA)
- Studies of Sulfur Metabolism in Humans (EARLY_PHASE1)
- A Study of Soticlestat With Itraconazole and Mefenamic Acid in Healthy Adults (PHASE1)
- Drug-drug Interaction Between Ciprofol and Mefanamic Acid or Valproate (PHASE1)
- Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin in Healthy Male and Female Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mefanamic Acid CI brief — competitive landscape report
- Mefanamic Acid updates RSS · CI watch RSS
- Haisco Pharmaceutical Group Co., Ltd. portfolio CI